About
Mark Yarchoan is an Associate Professor of Medical Oncology at Johns Hopkins with NCI-funded research in immunotherapy development, particularly cancer vaccines. He has conducted clinical trials of immunotherapy agents including neoantigen-targeted approaches.
Founder at Adventris PharmaceuticalsYC W23
Intro paths
Mark went through Y Combinator (Winter 2023) — any YC alum in your network can reach them through the YC community.
Their group partner at YC was Tom Blomfield, Monzo and GoCardless co-founder; Y Combinator partner on leave and Anthropic compute-team member. — the partner who ran Adventris Pharmaceuticals's batch and knows the company first-hand. YC profile ↗
In turn, Mark can intro founders to Adventris Pharmaceuticals's investors below.
Adventris Pharmaceuticals's investors · 3
Co-founders at Adventris Pharmaceuticals
Frequently asked questions
- Who is Mark Yarchoan?
- Mark Yarchoan is an Associate Professor of Medical Oncology at Johns Hopkins with NCI-funded research in immunotherapy development, particularly cancer vaccines. He has conducted clinical trials of immunotherapy agents including neoantigen-targeted approaches.
- Where does Mark Yarchoan work?
- Mark Yarchoan is Founder of Adventris Pharmaceuticals.
- What companies did Mark Yarchoan found?
- Mark Yarchoan founded Adventris Pharmaceuticals.
Founder mafias
Y Combinator mafia8,773
Also came through, then founded or led a company.
+ 8,766 more